UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: January 27, 2005
Date of earliest event reported: January 27, 2005
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
| | | | | |
| Delaware | | 1-1136 | | 22-079-0350 |
(State or Other
Jurisdiction of
Incorporation) | | (Commission File
Number) | | (IRS Employer
Identification
Number) |
345 Park Avenue
New York, NY, 10154
(Address of Principal Executive Office)
Registrant’s telephone number, including area code: (212) 546-4000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
| |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition
On January 27, 2005, Bristol-Myers Squibb Company issued a press release announcing its financial results for the fourth quarter of 2004 and full-year 2004. A copy of the press release is furnished as Exhibit 99.1 to this report and is also incorporated herein by reference. Also furnished and incorporated by reference as Exhibit 99.2 is supplemental information posted on Bristol-Myers Squibb Company’s website atwww.bms.com.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit 99.1 – Press release of Bristol-Myers Squibb Company dated January 27, 2005, reporting Bristol-Myers Squibb’s financial results for the fourth quarter of 2004 and full-year 2004.
Exhibit 99.2 – Certain supplemental information posted on Bristol-Myers Squibb’s website atwww.bms.com not included in the press release.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the authorized undersigned.
| | | | | |
| | BRISTOL-MYERS SQUIBB COMPANY
| |
| | By: | /s/ Sandra Leung | |
| | | Sandra Leung | |
| Dated: January 27, 2005 | | Title: | Vice President and Secretary | |
EXHIBIT INDEX
| | | |
| Exhibit No. | | Description |
| 99.1 | | Press release of Bristol-Myers Squibb Company dated January 27, 2005, reporting Bristol-Myers Squibb’s financial results for the fourth quarter of 2004 and full-year 2004. |
| | | |
| 99.2 | | Certain supplemental information posted on the Company’s website on www.bms.com not included in the press release. |
